131 related articles for article (PubMed ID: 37645696)
1. Intratumoral
Yu S; Chen J; Yan F; Chen X; Zhao Y; Zhang P
MedComm (2020); 2023 Oct; 4(5):e344. PubMed ID: 37645696
[No Abstract] [Full Text] [Related]
2.
Mougeot JC; Beckman MF; Langdon HC; Lalla RV; Brennan MT; Bahrani Mougeot FK
Front Microbiol; 2021; 12():794546. PubMed ID: 35116012
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities and spectrum of lascufloxacin（KRP-AM1977）against anaerobes.
Tanaka K; Vu H; Hayashi M
J Infect Chemother; 2021 Aug; 27(8):1265-1269. PubMed ID: 33867268
[TBL] [Abstract][Full Text] [Related]
4. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
5.
Ranganath N; Shirley JD; Challener DW; Stevens RW; Kind DR; Comba IY; Patel R; Schuetz AN; Shah AS
J Clin Microbiol; 2023 Feb; 61(2):e0173322. PubMed ID: 36715514
[No Abstract] [Full Text] [Related]
6. Leptotrichia bacteremia in patients receiving high-dose chemotherapy.
Couturier MR; Slechta ES; Goulston C; Fisher MA; Hanson KE
J Clin Microbiol; 2012 Apr; 50(4):1228-32. PubMed ID: 22205794
[TBL] [Abstract][Full Text] [Related]
7. Monitoring tumor proliferative response to radiotherapy using (18)F-fluorothymidine in human head and neck cancer xenograft in comparison with Ki-67.
Fatema CN; Zhao S; Zhao Y; Murakami M; Yu W; Nishijima K; Tamaki N; Kitagawa Y; Kuge Y
Ann Nucl Med; 2013 May; 27(4):355-62. PubMed ID: 23417197
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers.
Wallis SP; Stafford ND; Greenman J
Head Neck; 2015 Mar; 37(3):449-59. PubMed ID: 24803283
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of gene therapy in head and neck cancer.
Karamouzis MV; Argiris A; Grandis JR
Curr Gene Ther; 2007 Dec; 7(6):446-57. PubMed ID: 18045104
[TBL] [Abstract][Full Text] [Related]
10. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral delivery of docetaxel enhances antitumor activity of Ad-p53 in murine head and neck cancer xenograft model.
Yoo GH; Subramanian G; Ezzat WH; Tulunay OE; Tran VR; Lonardo F; Ensley JF; Kim H; Won J; Stevens T; Zumstein LA; Lin HS
Am J Otolaryngol; 2010; 31(2):78-83. PubMed ID: 20015717
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancer.
Audet N; Beasley NJ; MacMillan C; Jackson DG; Gullane PJ; Kamel-Reid S
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1065-70. PubMed ID: 16365219
[TBL] [Abstract][Full Text] [Related]
13. Phase 2 study of intratumoral cisplatin and epinephrine treatment for locally recurrent head and neck tumors.
Duvillard C; Romanet P; Cosmidis A; Beaudouin N; Chauffert B
Ann Otol Rhinol Laryngol; 2004 Mar; 113(3 Pt 1):229-33. PubMed ID: 15053208
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial.
Rühle A; Wiedenmann N; Fennell JT; Mix M; Ruf J; Stoian R; Thomsen AR; Vaupel P; Baltas D; Grosu AL; Nicolay NH
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1650-1660. PubMed ID: 34773163
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.
Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL
Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of Leptotrichia amnionii sp. nov. in pregnant women].
Kwaśniewska A; Nawrot R; Skoczyński M; Semczuk-Sikora A; Kuźma D; Goździcka-Józefiak A
Ginekol Pol; 2006 Jul; 77(7):523-6. PubMed ID: 17076202
[TBL] [Abstract][Full Text] [Related]
17. Proposal to reclassify
Eisenberg T; Glaeser SP; Blom J; Kämpfer P
Int J Syst Evol Microbiol; 2020 Mar; 70(3):2084-2088. PubMed ID: 32228774
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
Maula SM; Luukkaa M; Grénman R; Jackson D; Jalkanen S; Ristamäki R
Cancer Res; 2003 Apr; 63(8):1920-6. PubMed ID: 12702584
[TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma.
Partlová S; Bouček J; Kloudová K; Lukešová E; Zábrodský M; Grega M; Fučíková J; Truxová I; Tachezy R; Špíšek R; Fialová A
Oncoimmunology; 2015 Jan; 4(1):e965570. PubMed ID: 25949860
[TBL] [Abstract][Full Text] [Related]
20. Restoration of the Oral Microbiota After Surgery for Head and Neck Squamous Cell Carcinoma Is Associated With Patient Outcomes.
Chan JYK; Ng CWK; Lan L; Fung S; Li JW; Cai L; Lei P; Mou Q; Meehan K; Lau EHL; Yeung Z; Chan KCA; Wong EWY; Chan PKS; Chen Z
Front Oncol; 2021; 11():737843. PubMed ID: 34692514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
